LekoskopLekoskop
UK · ES · FR · CS · IT · NL · CH · HR · PL

Medicine recalls, shortages and safety updates in the UK

MHRA medicines recalls and defect notifications with batch numbers, Serious Shortage Protocols, new approvals and Drug Safety Update — updated daily, automatically. Last updated: 27 Sep 2026 13:39.

All Recalls and defects2 Serious shortages (SSP)2 New approvals1 Drug Safety Update1
clear

Sources: we track changes based on information published by the MHRA — medicines recalls and defect notifications, Drug Safety Update and approval announcements — and the Serious Shortage Protocols published by the NHS Business Services Authority. The UK is outside the EU, so European Commission decisions are not listed here.

29 Jan 2026Thursday 29 January 2026

open day ◀ ▶ 1 event · 1 important
Drug Safety Update GLP
The product information for all Glucagon-Like Peptide-1 (GLP-1) receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists has been further updated to highli…
What this means, batches, details

Loading…

28 Jan 2025Tuesday 28 January 2025

open day ◀ ▶ 1 event · 1 important
Drug Safety Update GLP
Healthcare professionals should be aware of the potential risk of pulmonary aspiration in patients using GLP-1 or dual GIP/GLP-1 receptor agonists who undergo surgery or procedures with general anaest…
What this means, batches, details

Loading…

24 Oct 2024Thursday 24 October 2024

open day ◀ ▶ 1 event · 1 important
Drug Safety Update GLP
Healthcare professionals are reminded to inform patients about the common and serious side effects associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs).
What this means, batches, details

Loading…

23 Jul 2024Tuesday 23 July 2024

open day ◀ ▶ 1 event
Semaglutide is the first weight loss drug approved in the UK as a preventative treatment for those with established cardiovascular disease
What this means, batches, details

Loading…

In total 4 events.